Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company developing adeno-associated virus vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. The company was founded in 2015 and is headquartered in Stevenage, U.K.